These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 19527764
61. Adult attention-deficit hyperactivity disorder in patients with bipolar I disorder in remission: preliminary study. Tamam L, Tuğlu C, Karatas G, Ozcan S. Psychiatry Clin Neurosci; 2006 Aug; 60(4):480-5. PubMed ID: 16884451 [Abstract] [Full Text] [Related]
62. Early age at onset of bipolar disorder is associated with more severe clinical features but delayed treatment seeking. Suominen K, Mantere O, Valtonen H, Arvilommi P, Leppämäki S, Paunio T, Isometsä E. Bipolar Disord; 2007 Nov; 9(7):698-705. PubMed ID: 17988359 [Abstract] [Full Text] [Related]
63. [Total antioxidant status concentration in blood plasma of professional sportsmen after dosed physical exercise]. Mrowicka M, Bortnik K, Malinowska K, Kedziora J, Mrowicki J. Pol Merkur Lekarski; 2009 Jul; 27(157):22-5. PubMed ID: 19650424 [Abstract] [Full Text] [Related]
64. DNA damage in children with asthma bronchiale and its association with oxidative and antioxidative measurements. Zeyrek D, Cakmak A, Atas A, Kocyigit A, Erel O. Pediatr Allergy Immunol; 2009 Jun; 20(4):370-6. PubMed ID: 18801009 [Abstract] [Full Text] [Related]
65. Total antioxidant response in patients with schizophrenia. Ustundag B, Atmaca M, Kirtas O, Selek S, Metin K, Tezcan E. Psychiatry Clin Neurosci; 2006 Aug; 60(4):458-64. PubMed ID: 16884448 [Abstract] [Full Text] [Related]
66. DNA damage in bipolar disorder. Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Gonçalves CA, Kapczinski F. Psychiatry Res; 2007 Sep 30; 153(1):27-32. PubMed ID: 17582509 [Abstract] [Full Text] [Related]
67. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Torun AN, Kulaksizoglu S, Kulaksizoglu M, Pamuk BO, Isbilen E, Tutuncu NB. Clin Endocrinol (Oxf); 2009 Mar 30; 70(3):469-74. PubMed ID: 18727709 [Abstract] [Full Text] [Related]
68. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Matthews AM, Huckans MS, Blackwell AD, Hauser P. Bipolar Disord; 2008 Mar 30; 10(2):266-70. PubMed ID: 18271905 [Abstract] [Full Text] [Related]
69. Demographic and diagnostic characteristics of the first 1000 patients enrolled in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Kogan JN, Otto MW, Bauer MS, Dennehy EB, Miklowitz DJ, Zhang HW, Ketter T, Rudorfer MV, Wisniewski SR, Thase ME, Calabrese J, Sachs GS, STEP-BD Investigators. Bipolar Disord; 2004 Dec 30; 6(6):460-9. PubMed ID: 15541061 [Abstract] [Full Text] [Related]
70. Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes. Akiskal HS, Akiskal KK, Lancrenon S, Hantouche EG, Fraud JP, Gury C, Allilaire JF. J Affect Disord; 2006 Dec 30; 96(3):197-205. PubMed ID: 16824616 [Abstract] [Full Text] [Related]
71. The role of oxidative stress in early-onset androgenetic alopecia. Kaya Erdogan H, Bulur I, Kocaturk E, Yildiz B, Saracoglu ZN, Alatas O. J Cosmet Dermatol; 2017 Dec 30; 16(4):527-530. PubMed ID: 27987270 [Abstract] [Full Text] [Related]
72. Selective deficit of autobiographical incident memory in subjects with bipolar disorder. Shimizu M, Kubota Y, Mason R, Baba H, Calabrese JR, Toichi M. Psychopathology; 2009 Dec 30; 42(5):318-24. PubMed ID: 19672134 [Abstract] [Full Text] [Related]
73. [Oxidant-antioxidant status of patients with bronchial asthma during inhalation and systemic glucocorticoid therapy]. Varshavskiĭ BIa, Trubnikov GV, Galaktipmpva LP, Koreniak NA, Koledeznaia IL, Oberemok AN. Ter Arkh; 2003 Dec 30; 75(3):21-4. PubMed ID: 12718214 [Abstract] [Full Text] [Related]
74. Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder. Chang CC, Jou SH, Lin TT, Liu CS. Psychiatry Clin Neurosci; 2014 Jul 30; 68(7):551-7. PubMed ID: 24447331 [Abstract] [Full Text] [Related]
75. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Dias VV, Brissos S, Frey BN, Andreazza AC, Cardoso C, Kapczinski F. Bipolar Disord; 2009 Sep 30; 11(6):663-71. PubMed ID: 19689509 [Abstract] [Full Text] [Related]
76. Fear of harm, a possible phenotype of pediatric bipolar disorder: a dimensional approach to diagnosis for genotyping psychiatric syndromes. Papolos D, Mattis S, Golshan S, Molay F. J Affect Disord; 2009 Nov 30; 118(1-3):28-38. PubMed ID: 19631388 [Abstract] [Full Text] [Related]
77. Influence of therapy on the antioxidant status in patients with melanoma. Gadjeva V, Dimov A, Georgieva N. J Clin Pharm Ther; 2008 Apr 30; 33(2):179-85. PubMed ID: 18315784 [Abstract] [Full Text] [Related]
78. N-acetylaspartate levels in bipolar offspring with and at high-risk for bipolar disorder. Gallelli KA, Wagner CM, Karchemskiy A, Howe M, Spielman D, Reiss A, Chang KD. Bipolar Disord; 2005 Dec 30; 7(6):589-97. PubMed ID: 16403184 [Abstract] [Full Text] [Related]
79. Only half of bipolar I and II patients report prodromal symptoms. Mantere O, Suominen K, Valtonen HM, Arvilommi P, Isometsä E. J Affect Disord; 2008 Dec 30; 111(2-3):366-71. PubMed ID: 18442858 [Abstract] [Full Text] [Related]
80. Hopelessness across phases of bipolar I or II disorder: a prospective study. Valtonen HM, Suominen K, Haukka J, Mantere O, Arvilommi P, Leppämäki S, Isometsä ET. J Affect Disord; 2009 May 30; 115(1-2):11-7. PubMed ID: 18678413 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]